SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$13.34
Tradestie Score
48
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
+143.6%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$25.21
|
$2.89B | - | 51 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$40.82
|
$2.85B | - | 43 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$29.43
|
$2.44B | - | 42 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$74.24
|
$2.42B | - | 42 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$155.71
|
$2.41B | - | 38 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$40.10
|
$2.40B | - | 41 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
More SLS Analysis
Data updated: Aug 31, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry